ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies

Contributed by: Business Wire

Logo

Tags

Research

Technology

Medical Devices

Health Technology

Software

Biotechnology

Pharmaceutical

Health

Science

Artificial Intelligence

portfolio of AI tools

More Like This

ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption

ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer

ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research

ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON

Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey

ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape

ICON plc Schedules Third Quarter 2024 Earnings Conference Call